Skip to main content
WORX
OTC Technology

SCWorx Schedules Shareholder Vote on Second Reverse Stock Split to Re-list on Nasdaq

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.302
Mkt Cap
$322.444K
52W Low
$0.26
52W High
$147.735
52W Position info
16% above low
Off High info
100% below high
Rel. Volume
Market data snapshot near publication time

WORX sits 16% above its 52-week low of $0.26.

Summary

SCWorx Corp. has filed its definitive proxy statement, scheduling a shareholder meeting for July 22, 2026, to vote on a second reverse stock split (1-for-1.5 to 1-for-10) aimed at regaining Nasdaq compliance, following a previous failed reverse split and delisting.


Key Events · Corporate Governance and Compliance · WORX

  • Shareholder Meeting Scheduled

    The annual meeting of shareholders is set for July 22, 2026, to vote on several key proposals.

  • Second Reverse Stock Split Proposed

    Shareholders will vote on a proposal to effect another reverse stock split, ranging from 1-for-1.5 to 1-for-10, to regain compliance with Nasdaq's $1.00 minimum bid price rule. This follows a 1-for-15 reverse split in April 2026 that failed to prevent delisting.

  • Auditor Ratification

    Shareholders will vote to ratify Astra Audit & Advisory, LLC as the independent registered public accounting firm for 2026. This firm replaced BF Borgers CPA PC, which was denied the privilege of practicing before the SEC.

  • Potential Future Dilution

    The company stated it may seek to finance future cash needs through public or private equity offerings, potentially occurring concurrently with or soon after the proposed reverse split.


Analysis · WORX · Technology

This definitive proxy statement confirms SCWorx's ongoing struggle for survival and re-listing on Nasdaq. The proposal for a second reverse stock split, just months after a 1-for-15 split failed to prevent delisting, highlights the company's severe financial distress and the urgent need to meet listing requirements. The explicit mention of potential future equity financings "concurrently with or soon after" the reverse split indicates significant future dilution risk. The ratification of a new auditor due to the previous one being barred by the SEC further underscores the company's compliance challenges and past financial reporting issues.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 52.8% of the 195 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.69%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, WORX was trading at $0.30 on OTC in the Technology sector, with a market capitalization of approximately $322.4K. The 52-week trading range was $0.26 to $147.74. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

WORX - Latest Insights

WORX
Oct 27, 2026, 9:42 AM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $2.04
Real-time Price: $1.16 info
Change: -$0.8796 (-43%) info
Market Cap: $1.595M info
WORX
Oct 23, 2026, 11:43 AM EDT
Filing Type: S-3/A
Importance Score:
7
Price at Filing: $2.60
Real-time Price: $1.16 info
Change: -$1.44 (-55%) info
Market Cap: $1.595M info
WORX
Oct 16, 2026, 2:23 PM EDT
Filing Type: S-3
Importance Score:
8
Price at Filing: $1.74
Real-time Price: $1.16 info
Change: -$0.580 (-33%) info
Market Cap: $1.595M info
WORX
Oct 07, 2026, 2:23 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $6.11
Real-time Price: $1.16 info
Change: -$4.95 (-81%) info
Market Cap: $1.595M info
WORX
Oct 05, 2026, 1:08 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $5.17
Real-time Price: $1.16 info
Change: -$4.01 (-78%) info
Market Cap: $1.595M info